Ad
ADMA Stock - ADMA Biologics Inc Stock Trading
About | ADMA Biologics Inc (NASDAQ:ADMA)
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.
Quote | ADMA Biologics Inc (NASDAQ:ADMA)
| Last: | $18.43 |
|---|---|
| Change Percent: | -1.23% |
| Open: | $18.13 |
| Close: | $18.43 |
| High: | $18.57 |
| Low: | $17.835 |
| Volume: | 2,551,336 |
| Last Trade Date Time: | 03/14/2025 03:00:00 am |
News | ADMA Biologics Inc (NASDAQ:ADMA)
-
2025-03-12 17:49:06 ET Summary Zacks Small/Mid Cap ETF focuses on earnings revisions and surprises, aiming for consistent returns with minimal capital loss. The SMIZ ETF has a portfolio of 216 U.S. stocks, primarily small/micro caps, with a tilt to growth. SMIZ has outperforme...
-
2025-03-04 11:52:16 ET More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add ADMA Biologics GAAP EPS of $0.46 beats by $0.31, revenue of $117.55M beats by $4.75M See...
Message Board Posts | ADMA Biologics Inc (NASDAQ:ADMA)
| Subject | By | Source | When |
|---|---|---|---|
| $ADMA Adma Biologics Inc | mick | investorshub | 04/30/2023 9:11:34 PM |
| ad-ma $ADMA | mick | investorshub | 04/15/2023 3:16:50 PM |
| $ADMA Adma Biologics Inc | mick | investorshub | 02/27/2023 12:15:20 AM |
| Looks like a double pointed top forming I | bude | investorshub | 02/09/2023 3:08:09 PM |
| Look at the weekly and monthly charts for | bude | investorshub | 02/09/2023 1:42:24 PM |
News, Short Squeeze, Breakout and More Instantly...
ADMA Biologics Inc Company Name:
ADMA Stock Symbol:
NASDAQ Market:
-1.23% G/L:
$18.43 Last:
2,551,336 Volume:
$18.13 Open:
$18.43 Close:
ADMA Biologics Inc Website:
Ad
-
BBB Foods Inc. Class A (TBBB) is expected to report $0.02 for Q4 2024 Beamr Imaging Ltd. (BMR) is expected to report for quarter end 2024-12-31 Transportadora de Gas del Sur SA TGS (TGS) is expected to report $0.5 for Q4 2024 Henkel AG & Co. KGAA ADR (HENKY) is expected to report ...
-
XPEL Inc. (XPEL) is expected to report $0.41 for Q4 2024 MGP Ingredients Inc. (MGPI) is expected to report $1.49 for Q4 2024 Kratos Defense & Security Solutions Inc. (KTOS) is expected to report $0.05 for Q4 2024 Albany International Corporation (AIN) is expected to report $0.65 f...
- ADMA - ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today annou...
Important Investor News Alert (OTC: AVAI)
-
LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), tod...